Endoscopic Accessories Used for More Advanced Endoluminal Therapeutic Procedures

키워드

참고문헌 (52)

1. Carla Maradey-Romero, "New and Future Drug Development for Gastroesophageal Reflux Disease", Journal of Neurogastroenterology and Motility (JNM), 20(1), pp.6~16 (2014), 대한소화기 기능성질환∙운동학회
2. Chung H, "Noninvasive prediction of erosive esophagitis using a controlled attenuation parameter (CAP)-based risk estimation model", Dig Dis Sci, 61, pp.507~516 (2016)
3. Kim KM, "Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study", J Gastroenterol Hepatol, 27, pp.741~745 (2012)
4. El-Serag HB, "Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review", Gut, 63, pp.871~880 (2014)
5. Lazarus B, "Proton pump inhibitor use and the risk of chronic kidney disease", JAMA Intern Med, 176, pp.238~246 (2016)
6. Abraham NS, "Proton pump inhibitors: potential adverse effects", Curr Opin Gastroenterol, 28, pp.615~620 (2012)
7. Yew KC, "Antireflux endoluminal therapies: past and present", Gastroenterol Res Pract, 2013, pp.481417~ (2013)
8. Du X, "A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270degrees ) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults", BMC Gastroenterol, 16, pp.88~ (2016)
9. Triadafilopoulos G, "Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease", World J Gastroenterol, 20, pp.7730~7738 (2014)
10. Arts J, "A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD", Am J Gastroenterol, 107, pp.222~230 (2012)
11. DiBaise JK, "Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action", Am J Gastroenterol, 97, pp.833~842 (2002)
12. Noar M, "Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later", Surg Endosc, 28, pp.2323~2333 (2014)
13. Auyang ED, "SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD)", Surg Endosc, 27, pp.2658~2672 (2013)
14. Higuchi K, "Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from Asia", J Gastroenterol, 42, pp.205~210 (2007)
15. "Interstitial cells of Cajal (ICCs)and smooth muscle actin (SMA) activity after non-ablative radiofrequency energy application to the internal anal sphincter (IAS): an animal study" (2013)[URL]
16. Testoni PA, "Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes", World J Gastrointest Pharmacol Ther, 7, pp.179~189 (2016)
17. Obesity: preventing and managing the global epidemic, "Report of a WHO consultation", World Health Organ Tech Rep Ser, 894, pp.1~253 (2000)
18. "OECD health statistics" (2015)[URL]
19. Hankey CR, "Session 3 (Joint with the British dietetic association): management of obesity: weight-loss interventions in the treatment of obesity", Proc Nutr Soc, 69, pp.34~38 (2010)
20. Sjöström L, "Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery", N Engl J Med, 351, pp.2683~2693 (2004)
21. Obeid NR, "Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data", Surg Obes Relat Dis, 12, pp.11~20 (2016)
22. van Rijn S, "Structural endoscopic techniques to treat obesity: a review", Surg Technol Int, 26, pp.84~91 (2015)
23. Abu Dayyeh BK, "Clinical practice update:expert review on endoscopic bariatric therapies", Gastroenterology, 152, pp.716~729 (2017)
24. Kumar N, "Endoscopic sleeve gastroplasty for primary therapy of obesity: initial human cases", Gastroenterology, 146(5), pp.S571~S572 (2014)
25. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals", Clin Gastroenterol Hepatol, 15, pp.37~43 (2017)
26. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity", Gastrointest Endosc, 78, pp.530~535 (2013)
27. Sharaiha RZ, "Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population", Endoscopy, 47, pp.164~166 (2015)
28. Lopez-Nava G, "Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success", Endosc Int Open, 4, pp.E222~E227 (2016)
29. Lopez-Nava G, "Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up", Gastroenterology, 150(4), pp.S26~ (2016)
30. Kumar N, "Endoscopic sleeve gastroplasty: multicenter weight loss results", Gastroenterology, 148(4), pp.S~179 (2015)
31. Gomez V, "Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy:results of a prospective study", Obesity (Silver Spring), 24, pp.1849~1853 (2016)
32. Mion F, "Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients", Obes Surg, 15, pp.510~516 (2005)
33. Genco A, "BioEnterics intragastric balloon: the Italian experience with 2,515 patients", Obes Surg, 15, pp.1161~1164 (2005)
34. Farina MG, "Intragastric balloon in association with lifestyle and", or pharmacotherapy in the long-term management of obesity, 2012, pp.22, 565~571
35. Sampath K, "Selected endoscopic gastric devices for obesity", Gastrointest Endosc Clin N Am, 27, pp.267~275 (2017)
36. Marinos G, "Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study", Surg Obes Relat Dis, 10, pp.929~934 (2014)
37. Schjoldager B, "Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions", Dig Dis Sci, 34, pp.1411~1419 (1989)
38. Tsoli M, "Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study", Surg Obes Relat Dis, 9, pp.667~677 (2013)
39. Yousseif A, "Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans", Obes Surg, 24, pp.241~252 (2014)
40. Jirapinyo P, "Endoscopic bariatric and metabolic therapies:surgical analogues and mechanisms of action", Clin Gastroenterol Hepatol, 15, pp.619~630 (2017)
41. Fishman E, "A novel endoscopic delivery system for placement of a duodenal-jejunal implant for the treatment of obesity and type 2 diabetes", Conf Proc IEEE Eng Med Biol Soc 2008, pp.2501~2503 (2008)
42. Jain D, "Endoscopic bypass using Endobarrier devices: efficacy in treating obesity and metabolic syndrome", J Clin Gastroenterol, 49, pp.799~803 (2015)
43. Koehestanie P, "The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation", Surg Endosc, 28, pp.325~330 (2014)
44. Schouten R, "A multicenter, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery", Ann Surg, 251, pp.236~243 (2010)
45. Rohde U., "EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects", Dan Med J, 63 (2016)
46. Rohde U, "Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis", Diabetes Obes Metab, 18, pp.300~305 (2016)
47. Patel SR, "The duodenal-jejunal bypass sleeve (EndoBarrier gastrointestinal liner) for weight loss and treatment of type II diabetes", Indian J Surg, 74, pp.275~277 (2012)
48. Patel SR, "The duodenal-jejunal bypass sleeve (EndoBarrier gastrointestinal liner) for weight loss and treatment of type 2 diabetes", Surg Obes Relat Dis, 9, pp.482~484 (2013)
49. Abu Dayyeh BK, "Endoscopic bariatric therapies", Gastrointest Endosc, 81, pp.1073~1086 (2015)
50. Bennett MC, "Endoscopic management", Gastroenterol Clin North Am, 45, pp.673~688 (2016)
51. Cherrington AD, "Hydrothermal duodenal mucosal resurfacing: role in the treatment of metabolic disease", Gastrointest Endosc Clin N Am, 27, pp.299~311 (2017)
52. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)

관련 논문AI추천